Recently, the China National Intellectual Property Administration issued the Notice on Determining the Demonstration Creation Objects for the Construction of a National Intellectual Property Powerhouse (2025-2027). Chengdu Olymvax Biopharmaceuticals Inc. (hereinafter referred to as “Olymvax”) was successfully selected as a “National Intellectual Property Demonstration Enterprise Creation Object” by virtue of its systematic layout and outstanding achievements in the comprehensive management of intellectual property rights.

The work of “Demonstration Creation for the Construction of a National Intellectual Property Powerhouse” is an important measure to implement the Outline for Building a Strong Intellectual Property Country (2021-2035). It aims to select a number of enterprises with outstanding performance in the creation, application, protection and management of intellectual property rights, accelerate the building of demonstration models for the construction of a strong intellectual property country, effectively play a demonstration and leading role, and promote innovative development and high-quality economic development.

Olymvax is a global-oriented, innovation-driven biopharmaceutical enterprise focusing on the R&D, production and commercialization of human vaccines. The Company has always regarded intellectual property rights as the core strategic resource for enterprise innovation and development. In the long-term development, the Company has formed rich innovative achievements and intellectual property accumulation: it has obtained more than 80 authorized invention patents in total, including 3 US patents and 1 European patent; meanwhile, relying on solid work in intellectual property rights, the Company has successively been awarded honors such as “National Intellectual Property Advantage Enterprise”, “Sichuan Intellectual Property Strong Enterprise Cultivation Enterprise” and “Sichuan Foreign-related Intellectual Property Work Guidance Station”; in addition, its core technologies have won important awards such as the “Second Prize of Sichuan Patent Award” and the “Third Prize of China · Haidian High-value Patent Cultivation Competition”.

The successful selection as a “National Intellectual Property Demonstration Enterprise Creation Object” is an authoritative recognition of Olymvax’s comprehensive intellectual property strength. Taking this opportunity, the Company will continue to improve the comprehensive management level of intellectual property rights, deepen the path of technological innovation-driven development, actively play a demonstration role in the industry, and inject stronger impetus into the high-quality and sustainable development of the enterprise.